Mayne Pharma | MYX - 当期純利益

株価
2.54
毎日の変更
0.06 2.42%
毎月
-9.93%
毎年
-64.87%
Q1 予測
2.40




当期純利益 変化する 日付
Ansell USD 88.8M 65.5M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Healius AUD -12.8M 7.8M 2024-12
Integral Diagnostics AUD 6.06M 72.81M 2024-06
Medical Developments International AUD -226K 121K 2025-12
Nanosonics AUD 9.64M 4.18M 2025-12
Polynovo AUD 1.28M 1.41M 2024-06
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 392.59M 44.05M 2025-12
Sigma Healthcare AUD -6.72M 10.02M 2024-12
Sonic Healthcare AUD 236.68M 82.29M 2024-12
Telix Pharmaceuticals AUD -4.83M 2.54M 2025-12